Live Breaking News & Updates on Head Of Microbial Sciences

Stay updated with breaking news from Head of microbial sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

DARPA and JPEO-CBRND Award $37.6M to The Wistar Institute and Collaborators at INOVIO, ...

Press release content from Globe Newswire. The AP news staff was not involved in its creation.
DARPA and JPEO-CBRND Award $37.6M to The Wistar Institute and Collaborators at INOVIO, .
The Wistar InstituteDecember 15, 2020 GMT
PHILADELPHIA, Dec. 15, 2020 (GLOBE NEWSWIRE)
A team of scientists from The Wistar Institute, INOVIO, AstraZeneca, the Perelman School of Medicine at the University of Pennsylvania, and Indiana University has received a $37.6 million award over two years from the Defense Advanced Research Projects Agency (DARPA) and the Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense (JPEO-CBRND) for rapid preclinical development and translational studies of DNA-encoded monoclonal antibodies (DMAbs) as countermeasures for COVID-19. ....

United States , Indiana University , University Of Pennsylvania , Davidb Weiner , Pablo Tebas , Jesper Pallesen , Mark Esser , J Joseph Kim , Darien Sutton , National Cancer Institute , Head Of Microbial Sciences , Indiana University Research , Department Of Defense , Perelman School Of Medicine , Coalition For Epidemic Preparedness Innovations , Nuclear Defense , Defense Health Agency , Cancer Center , Program Executive Office For Chemical , Health Affairs , Vaccine Immunotherapy Center , Defense Advanced Research Projects Agency , Office Of The , Johns Hopkins Coronavirus Research Center , Wistar Institute , Perelman School ,

DARPA and JPEO-CBRND award $37.6M to The Wistar Institute and collaborators

Credit: The Wistar Institute
PHILADELPHIA (Dec. 15, 2020) A team of scientists from The Wistar Institute, INOVIO, AstraZeneca, the Perelman School of Medicine at the University of Pennsylvania, and Indiana University has received a $37.6 million award over two years from the Defense Advanced Research Projects Agency (DARPA) and the Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense (JPEO-CBRND) for rapid preclinical development and translational studies of DNA-encoded monoclonal antibodies (DMAbs) as countermeasures for COVID-19.
DMAbs, unlike conventional therapeutic antibodies, are administered as genetic blueprints that instruct the patient s body to build its own highly specific antibodies against pathogens, such as bacteria and viruses, and as immunotherapeutics for cancer. Conceptually DMAbs have advantages over traditional monoclonal antibodies in scale-up and delivery, which would rapidly benefit large populations. ....

United States , University Of Pennsylvania , Davidb Weiner , Pablo Tebas , Jesper Pallesen , Mark Esser , J Joseph Kim , National Cancer Institute , Head Of Microbial Sciences , Department Of Defense , Perelman School Of Medicine , Coalition For Epidemic Preparedness Innovations , Nuclear Defense , Indiana University , Defense Health Agency , Cancer Center , Program Executive Office For Chemical , Health Affairs , Vaccine Immunotherapy Center , Defense Advanced Research Projects Agency , Office Of The , Johns Hopkins Coronavirus Research Center , Wistar Institute , Perelman School , Joint Program Executive Office , Charitable Trust Professor ,

INOVIO to Develop DNA-encoded Monoclonal Antibody (dMAb®) Candidates to Treat COVID-19 with Funding from the Defense Advanced Research Projects Agency (DARPA)

Published: Dec 15, 2020

PLYMOUTH MEETING, Pa., Dec. 15, 2020 /PRNewswire/ Inovio (NASDAQ:INO), a biotechnology company focused on bringing to market precisely designed DNA medicines to treat and protect people from infectious diseases and cancer, today announced the company and a team of scientists from The Wistar Institute, AstraZeneca, the University of Pennsylvania, and Indiana University received a $37.6 million grant from the Defense Advanced Research Projects Agency (DARPA) (DARPA), a research and development agency of the U.S. Department of Defense (DoD) and the Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense (JPEO-CBRND), to use INOVIO s innovative DNA-encoded monoclonal antibody (dMAb ....

Ben Matone , Jeff Richardson , Mark Esser , Darioc Altieri , Kaneka Eurogentec , J Joseph Kim , Walter Reed Army Institute Of Research , Us Department Of Defense , National Cancer Institute , Head Of Microbial Sciences , Department Of Defense , National Institute Of Allergy , Us Department Of Defense Do , Plumbline Life Sciences , Melinda Gates Foundation , Coalition For Epidemic Preparedness Innovations , International Vaccine Institute , Defense Consortium , Parker Institute For Cancer Immunotherapy , Nuclear Defense , Indiana University , National Institutes Of Health , Program Executive Office For Chemical , Apollobio Corporation , Defense Advanced Research Projects Agency , Vaccines Trial Network ,